Cargando…
Optimizing the data combination rule for seamless phase II/III clinical trials
We consider seamless phase II/III clinical trials that compare K treatments with a common control in phase II then test the most promising treatment against control in phase III. The final hypothesis test for the selected treatment can use data from both phases, subject to controlling the familywise...
Autores principales: | Hampson, Lisa V, Jennison, Christopher |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BlackWell Publishing Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288236/ https://www.ncbi.nlm.nih.gov/pubmed/25315892 http://dx.doi.org/10.1002/sim.6316 |
Ejemplares similares
-
Unbiased estimation in seamless phase II/III trials with unequal treatment effect variances and hypothesis‐driven selection rules
por: Robertson, David S., et al.
Publicado: (2016) -
Data-driven treatment selection for seamless phase II/III trials incorporating early-outcome data
por: Kunz, Cornelia Ursula, et al.
Publicado: (2014) -
Lung Cancer Clinical Trials with a Seamless Phase II/III Design: Systematic Review
por: Palermos, Dionysios, et al.
Publicado: (2022) -
An adaptive seamless phase II/III clinical trial design incorporating short-term endpoint information
por: Stallard, Nigel
Publicado: (2011) -
Using dichotomized survival data to construct a prior distribution for a Bayesian seamless Phase II/III clinical trial
por: Duputel, Benjamin, et al.
Publicado: (2023)